UNIGE document Scientific Article
previous document  unige:127234  next document
add to browser collection
Title

Targeting self- and neoepitopes with a modular self-adjuvanting cancer vaccine

Authors
Belnoue, Elodie
Mayol, Jean-François
Carboni, Susanna
Di Berardino Besson, Wilma
Nelde, Annika
Stevanovic, Stefan
Santiago-Raber, Marie-Laure
show hidden authors show all authors [1 - 10]
Published in JCI Insight. 2019, vol. 4, no. 11
Abstract Induction of a potent CD4 and CD8 T-cell response against tumor-specific and tumor-associated antigen is critical for eliminating tumor cells. Recent vaccination strategies have been hampered by an inefficacious and low amplitude immune response. Here we describe a self-adjuvanted chimeric protein vaccine platform to address these challenges, characterized by a multidomain construction incorporating (i) a cell penetrating peptide (CPP) allowing internalization of several multiantigenic Major Histocompatibility Complex (MHC)-restricted peptides within (ii) the multiantigenic domain (Mad) and (iii) a TLR2/4 agonist domain (TLRag). Functionality of the resulting chimeric protein is based on the combined effect of the above-mentioned three different domains for simultaneous activation of antigen presenting cells and antigen cross-presentation, leading to an efficacious multiantigenic and multiallelic cellular immune response. Helper and cytotoxic T-cell responses were observed against model-, neo- and self-antigens, and were highly potent in several murine tumor models. The safety and the immunogenicity of a human vaccine candidate designed for colorectal cancer treatment was demonstrated in a non-human primate model. This newly engineered therapeutic vaccine approach is promising for the treatment of poorly infiltrated tumors that do not respond to currently marketed immunotherapies.
Identifiers
PMID: 31013258
Full text
Article (Published version) (1.3 MB) - document accessible for UNIGE members only Limited access to UNIGE
Other version: https://insight.jci.org/articles/view/127305
Structures
Research group Immunobiologie des tumeurs du cerveau (669)
Citation
(ISO format)
BELNOUE, Elodie et al. Targeting self- and neoepitopes with a modular self-adjuvanting cancer vaccine. In: JCI Insight, 2019, vol. 4, n° 11. doi: 10.1172/jci.insight.127305 https://archive-ouverte.unige.ch/unige:127234

23 hits

0 download

Update

Deposited on : 2019-12-02

Export document
Format :
Citation style :